Showing results (1551-1560 of 9,979) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|April 12, 2013
The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemiaLisa M Baumann Kreuziger, Gobind Tarchand, Vicki A MorrisonLeukemia & Lymphoma|April 12, 2013
Modulation of natural killer cell effector functions through lenalidomide/dasatinib and their combined effects against multiple myeloma cellsIsabel Jungkunz-Stier, Michael Zekl, Thorsten Stühmer, et al.Leukemia & Lymphoma|April 12, 2013
IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1)Marianne Tinguely, Svenja Thies, Simona Frigerio, et al.Leukemia & Lymphoma|July 2, 2013
Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort studyAnnie Fourrier-Réglat, Pernelle Noize, Thierry Facon, et al.Leukemia & Lymphoma|April 27, 2013
Predictive value of [¹⁸F]fluoro-2-deoxy-D-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplantWenli Qiao, Jinhua Zhao, Yan Xing, et al.Leukemia & Lymphoma|July 9, 2013
Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian studyMervat Mamdooh Khorshied, Heba Mahmoud Gouda, Ola M Reda KhorshidLeukemia & Lymphoma|April 2, 2013
Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitorsHerman van Besien, Antonella Sassano, Jessica K Altman, et al.Leukemia & Lymphoma|December 5, 2012
A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphomaShireen Kassam, Mark Bower, Siow Ming Lee, et al.Leukemia & Lymphoma|December 6, 2012
Extramedullary multiple myelomaMatthew Weinstock, Irene M GhobrialLeukemia & Lymphoma|December 11, 2012
Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapyKyoko Ueda, Yasuhito Terui, Masahiro Yokoyama, et al.Pageof 998